Red sage 丹參
Pharmaceutical nameSalviae Miltiorrhizae Radix
The three axes are assessed independently and are never combined into a single score.
KTKP records the origin species as Salvia miltiorrhiza Bunge.. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The name most used for this taxon in current literature is Salvia miltiorrhiza. Literature searches for this herb also cover Salviae miltiorrhizae, Salvia miltiorrhizae — the same taxon appears under several names.
Tradition · what the text describes
탕액편
The sub-section within this volume has not been verified against the original text yet.
The KTKP traditional materia medica record (M0000791) gives the origin species as Salvia miltiorrhiza Bunge., the part used as 뿌리, and the properties as 고(苦), 무독(無毒), 미한(微寒). It lists 간(肝), 심(心) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.
Properties & channel entry: 고(苦), 무독(無毒), 미한(微寒) · 간(肝), 심(心)
Source species: Salvia miltiorrhiza Bunge. (뿌리)
Modern · documented evidence
Diabetic Kidney Diseaseevidence for this indication
- Systematic reviews were found but no RCTs. Check the search query (queryUsed).
- The indication was derived automatically from the Condition field of 3 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 3 · RCT 0 · preclinical 8
3 systematic review(s) and 0 RCT(s) were found. Size and consistency are not yet assessed.
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Salvia miltiorrhiza") OR (TITLE_ABS:"Salviae miltiorrhizae") OR (TITLE_ABS:"Salvia miltiorrhizae")) AND TITLE_ABS:"Diabetic Kidney Disease"- Protective Effects of Orally Administered Salvia miltiorrhiza-Derived Extracellular Vesicles on Diabetic Kidney Disease: Protection Mediated by Gut Microbiota and Metabolomic Remodeling. (2026 · research-article; Journal Article)
- [Different Astragalus medicinal pairs improve diabetic nephropathy in mice by regulating lipid peroxidation through PTGS2]. (2026 · research-article; Journal Article; English Abstract)
- Salvianolic acid C, a novel pyroptosis inhibitor, attenuates podocyte injury in diabetic kidney disease through regulating miRNA-21/A20 pathway. (2026 · Journal Article)
- Salvianolic Acids and Their Pharmacological Promise in Kidney Diseases: A Narrative Review. (2026 · review-article; Review; Journal Article)
- Effects and safety of Salvia miltiorrhiza on the improvement of renal function, inflammatory factors, and vascular endothelium in patients with diabetic kidney disease: a meta-analysis and systematic review. (2025 · Systematic Review; systematic-review; Journal Article)
- Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine. (2025 · review-article; Review; Journal Article)
- The Dual Role and Therapeutic Implications of the Wnt/β-Catenin Pathway in Diabetic Kidney Disease. (2025 · review-article; Review; Journal Article)
- Multi-omics analysis reveals the pathogenesis of db/db mice diabetic kidney disease and the treatment mechanisms of multi-bioactive compounds combination from Salvia miltiorrhiza. (2022 · research-article; Journal Article)
Clinical trials
- NCT07034807 — NOT_YET_RECRUITING · NA
- NCT07657351 — NOT_YET_RECRUITING · NA
- NCT07032116 — NOT_YET_RECRUITING
Unstable Anginaevidence for this indication
- The indication was derived automatically from the Condition field of 3 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 4 · RCT 1 · preclinical 0
4 systematic review(s) and 1 RCT(s) were found. Size and consistency are not yet assessed.
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Salvia miltiorrhiza") OR (TITLE_ABS:"Salviae miltiorrhizae") OR (TITLE_ABS:"Salvia miltiorrhizae")) AND TITLE_ABS:"Unstable Angina"- [Clinical research evidence map analysis of TCM in treatment of unstable angina pectoris in elderly patients]. (2026 · Systematic Review; Journal Article; English Abstract)
- Efficacy and safety of Danhong injection on inflammatory factors and vascular endothelial function in patients with unstable angina pectoris: a systematic review and meta-analysis of randomized clinical trials. (2025 · Systematic Review; systematic-review; Journal Article)
- Efficacy and safety of eight types Salvia miltiorrhiza injections in the treatment of unstable angina pectoris: A network meta-analysis. (2022 · Systematic Review; systematic-review; Journal Article)
- Efficacy of add-on Danhong injection in patients with unstable angina pectoris: A double-blind, randomized, placebo-controlled, multicenter clinical trial. (2022 · Multicenter Study; Randomized Controlled Trial; Journal Article)
- What are the best Salvia miltiorrhiza injection classes for treatment of unstable angina pectoris? A systematic review and network Meta-analysis. (2018 · Systematic Review; Journal Article)
Clinical trials
- NCT03179514 — UNKNOWN · PHASE4
- NCT03171597 — UNKNOWN · PHASE4
- NCT03179527 — UNKNOWN · PHASE4
Acute Mountain Sicknessevidence for this indication
- 3 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
- The indication was derived automatically from the Condition field of 3 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 0 · RCT 0 · preclinical 0
No human studies were found within the sources searched. This means "not yet studied", not "does not work".
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Salvia miltiorrhiza") OR (TITLE_ABS:"Salviae miltiorrhizae") OR (TITLE_ABS:"Salvia miltiorrhizae")) AND TITLE_ABS:"Acute Mountain Sickness"Clinical trials
- NCT03270787 — COMPLETED · PHASE1, PHASE2
- NCT04993729 — COMPLETED · PHASE3
- NCT03552263 — COMPLETED · PHASE2
Safety
auto-proposed · unreviewed
- 112 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
- 33 interaction-related record(s) are retrievable. This flags that literature exists — it is not an interaction checker (§3.4).
- The KTKP record states the following traditional contraindication: 무어혈자(無瘀血者)는 신용(愼用)한다.
Adverse-event and toxicity literature
This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.
- Efficacy and Safety of Salvia miltiorrhiza Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study. (2026 · Comparative Study; research-article; Randomized Controlled Trial; Journal Article)
- Salviae Miltiorrhizae Radix et Rhizoma protects against doxorubicin-induced cardiotoxicity: A systematic review. (2025 · Systematic Review; Journal Article)
- The multifaceted mechanisms of Tanshinone IIA in doxorubicin-induced cardiotoxicity. (2026 · review-article; Review; Journal Article)
- Interactions between cytochrome P450 enzymes and traditional Chinese herbs: A comprehensive review. (2026 · Journal Article)
- Salvianolic acid B attenuates drug-induced liver injury in an Nrf2-dependent mechanism via covalently modifying Keap1 at Cys395/Cys434. (2026 · Journal Article)
Interaction literature
This lists literature that is retrievable — it is not a judgement that an interaction exists. Read the papers to decide.
- Interactions between cytochrome P450 enzymes and traditional Chinese herbs: A comprehensive review. (2026 · Journal Article)
- Herbal Medicines and Drugs Interactions: Cytochrome P450 Responsibility. (2026 · Review; Journal Article)
- Formulation principles and mechanisms of TCM patent prescriptions for PCOS: A data mining study from CNIPA. (2025 · research-article; Journal Article)
- Evaluation of Herb-Drug Interaction Between Danshen and Rivaroxaban in Rat and Human Liver Microsomes. (2022 · research-article; Journal Article)
- Herb-Drug Interactions and Their Impact on Pharmacokinetics: An Update. (2023 · Review; Journal Article)
Sources
- KTKP materia medica (15002148) (fetched 2026-08-27)
- Europe PMC REST (fetched 2026-08-28)
- ClinicalTrials.gov API v2 (fetched 2026-08-28)
- Europe PMC REST (fetched 2026-08-28)
- ClinicalTrials.gov API v2 (fetched 2026-08-28)
- Europe PMC REST (fetched 2026-08-28)
- ClinicalTrials.gov API v2 (fetched 2026-08-28)
- KTKP materia medica (15002148) (fetched 2026-08-27)
- Europe PMC REST (fetched 2026-08-28)
Bridges from here
- In formulas
- 대아교원 · 천왕보심단